×

Notice

The forum is in read only mode.
Welcome, Guest
Username: Password: Remember me
  • Page:
  • 1
  • 2

TOPIC:

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16458

  • rohcvfighter
  • rohcvfighter's Avatar Topic Author
  • Offline
  • Platinum Member
  • Platinum Member
  • Vindecat de HCV cu med. generice. Cured with generics HCV drugs.
  • Posts: 389
  • Karma: 15
  • Thank you received: 1594
Hi Everybody,

in the latest press release from Gilead (for the first quarter of 2016), available at investors.gilead.com/phoenix.zhtml?c=69964&p=irol-earnings, there is a strange information, that by compare with the first quarter from 2015, the sales for Harvoni declined in US, while Sovaldi sales increased slightly, while in Europe Sovaldi sales decreased. Looking at the numbers, the drop in sales for antiviral products seems quite big (US -$1 billion)

Are perhaps US people knowing something more about the drug Harvoni than the rest of the world?

Regards,
RHF
In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google “medicamente generice pentru hepatita C”.
HCV kills more than 500000 people every year. HCV generic drugs work. Don't become a statistic.
By sharing this Youtube video you might save someone’s life!
My TX: HEPCVIR-L[generic Harvoni]-India
SVR52 achieved
The following user(s) said Thank You: mgalbrai, Ariel, Matt-Kenney-google, Meg, GT2

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16459

  • Meg
  • Meg's Avatar
  • Offline
  • Premium Member
  • Premium Member
  • Posts: 100
  • Karma: 12
  • Thank you received: 327
Interesting question RHF.
I was just checking their site too - but for info on the new drug to be approved by the FDA on June 28th.
Blood transfusion in 1992 - Diagnosed in 2007
Tx naive -G1b - F1
VL 2.270.000
ALT 40
Start tx June 4th/2016 with DAAs - Sof/Led from India
Bloods on two weeks of tx (June 18th)
AST 17 - ALT 10 - GGT 19
Virus UND
Bloods on six weeks of tx (July 16th)
AST 17 - ALT 8 - GGT 12
Virus UND
EOT on August 8th (did 9 weeks and 3 days)

SVR 4 Virus UND (September 7th)
AST 13 - ALT 5

SVR 14 Virus UND (November 12th)
The following user(s) said Thank You: Ariel, Matt-Kenney-google, GT2

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16464

  • Ariel
  • Ariel's Avatar
  • Offline
  • Platinum Member
  • Platinum Member
  • Cured, SVR 24
  • Posts: 1064
  • Karma: 31
  • Thank you received: 3084
Thankyou for the interesting read
It's hard to say why a drop in sales. I'm certain it won't be to do with the effectiveness or safety of the DAAs we have taken or are taking or for some, about to take. Like Meg I researched the new drug but information is sketchy.

Interesting snippets from this pdf include Gilead stating "....the potential pricing pressure from additional competitive HCV launches or austerity measures in European Countries and Japan....."

I'm still arguing the generic case and recoil at Gileads profit margins as we all do.
Another useful doc ty ROhcv for this
Cheers from Ariel
Gen 1a
Peg/inf/riba 2012(!) stop @ Wk 43 potassium low +issues (rlps week 4 post tx, VL120,000) scnds eg. adenomas.
pre sof/led VL 240,000 Fibsc F0
Day 25 <30
Day 32 UND
Week 10 UND
EOT UND ALT11AST17GGT19
SVR4 UND ALT10 AST16 GGT13
SVR8 UND ALT <9 AST16 GGT15
SVR12 UND ALT14 AST19 GGT12 Bili 5
EOT +18 ALT13 AST20 GGT9 Bili 5
EOT +21 ALT11AST15
Cured SVR12
Dysplasia Adenomas RemvdAug '16
SVR24 UND ALT11AST16
ColonoscopyClear Nov17
LumpectomyClear ‘18
LithotripsyCytoscopyBiopsy 4/18
The following user(s) said Thank You: mgalbrai, Matt-Kenney-google, Meg, GT2

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16466

  • beaches
  • beaches's Avatar
  • Offline
  • Platinum Member
  • Platinum Member
  • The life you save will be your own. START TREATMENT
  • Posts: 760
  • Karma: 25
  • Thank you received: 2254
Maybe it's the generics :P
Genotype 1a
Diagnosed in 2004, had HCV for all my adult life. Until 2016!!!!
Harvoni treatment, started 19 March 2016
4 week results Bilirubin 12 down from 14 pre treatment,
Gamma 25 down from 52, ALT 19 down from 63, AST 19 down from 47,
VL <15 down from a lazy 6 million or so

EOT Results
Bilirubin 10, GGT 18, ALT 19, AST 21, VL UND

12 Weeks post EOT
Bilirubin 11, GGT 16, ALT 22, AST 20, VL UND
Cured baby
The following user(s) said Thank You: Matt-Kenney-google, Meg, GT2

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16467

I also read that insurance companies continue to limit access to only the sickest patients, and that many are given only 8 weeks of treatment (less than 6 million VL) that is also cutting in to earnings.
Gt 1a, F0, VL 6.5 million, AST 59, ALT 62
Started Twinvir 1/15/16
6 wk. labs VL UND, AST 27, ALT 20
EOT labs VL UND, AST 23, ALT 19
SVR 16, VL UND, AST 28, ALT 17
SVR 24 , VL UND, 10/8/16
SVR 125, VL UND, 9/22/18
SVR 230, VL UND, 10/3/20
The following user(s) said Thank You: mgalbrai, Matt-Kenney-google, Meg, GT2

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16468

  • Gaj
  • Gaj's Avatar
  • Offline
  • Moderator
  • Moderator
  • Optimist :-)
  • Posts: 1436
  • Karma: 32
  • Thank you received: 3082
The market certainly doesn't seem happy with their performance. Big initial drop after the announcement with no recovery and in fact a slow worsening. This is a company that was at $1.20 in July last year with projections of $1.50 within 12 months. :evil:


G3a since '78 - Dx '12 - F4 (2xHCC)
24wk Tx - PEG/Riba/Dac 2013 relapsed
24wk Tx - Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx - 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 - 22/06/17 UND
SRV12 - 27/07/17 UND
SVR24 - 26/10/17 UND
:cheer: :cheer: :cheer:
Attachments:
The following user(s) said Thank You: mgalbrai, Hazel, Meg, GT2

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16488

  • DrJames
  • DrJames's Avatar
  • Offline
  • Platinum Member
  • Platinum Member
  • Posts: 1980
  • Karma: 111
  • Thank you received: 7263
Gilead's share price is down 32% from a peak of $122.21 on 23 June 2015 pre generics to $83.62 today - post generics.





Current market cap of $112 billion was $164 billion last year, so $52 billion dollars worth of greed has now dissolved before investors eyes.

$50 billion - that's $50,000,000,000 in investor losses, and last year 500,000 patients died of a now curable illness.

Coincidentally it works out at an investor loss of $100,000 per patient death, more or less exactly the same as the cost per cure.

Karma?
YMMV
Attachments:
The following user(s) said Thank You: poodle, mgalbrai, Gaj, beaches, Hazel, Greedfighter, Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16490

  • beaches
  • beaches's Avatar
  • Offline
  • Platinum Member
  • Platinum Member
  • The life you save will be your own. START TREATMENT
  • Posts: 760
  • Karma: 25
  • Thank you received: 2254
I always say to anyone who will listen (and to others as well) that if you own shares in big pharma you are profiting from death and misery
Genotype 1a
Diagnosed in 2004, had HCV for all my adult life. Until 2016!!!!
Harvoni treatment, started 19 March 2016
4 week results Bilirubin 12 down from 14 pre treatment,
Gamma 25 down from 52, ALT 19 down from 63, AST 19 down from 47,
VL <15 down from a lazy 6 million or so

EOT Results
Bilirubin 10, GGT 18, ALT 19, AST 21, VL UND

12 Weeks post EOT
Bilirubin 11, GGT 16, ALT 22, AST 20, VL UND
Cured baby
The following user(s) said Thank You: mgalbrai, Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16493

A lot of factors could be contributing to this decline in "blood money".
I would like to think generics is a major one.
m
This email address is being protected from spambots. You need JavaScript enabled to view it.
forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
The following user(s) said Thank You: beaches, Greedfighter, Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16494

  • DrJames
  • DrJames's Avatar
  • Offline
  • Platinum Member
  • Platinum Member
  • Posts: 1980
  • Karma: 111
  • Thank you received: 7263
Realistically generics are only a tiny contributor and represent one component of competition, but logically only a trivial part because if you have to chase generics, then by definition you're not in the (potentially) funded population.

And it's not undercutting pricing from Abbvie that's driving it either - their volumes are down too.

www.bidnessetc.com/58797-gilead-sciences...clining-hcv-scripts/

Effectively bankrupting the major payers like the VA and Medicaid is the primary cause.

Gilead and other pharmaceutical companies are strangling the geese that lay the golden eggs.
YMMV
The following user(s) said Thank You: Vororo, Gaj, Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16495

It seems to me the only way these prices will ever come down, is to make a legal case that these companies are 'profiteering' or 'price gouging'.

Seems a lot of politicians are either corrupt or cowards.
Gt 1a, F0, VL 6.5 million, AST 59, ALT 62
Started Twinvir 1/15/16
6 wk. labs VL UND, AST 27, ALT 20
EOT labs VL UND, AST 23, ALT 19
SVR 16, VL UND, AST 28, ALT 17
SVR 24 , VL UND, 10/8/16
SVR 125, VL UND, 9/22/18
SVR 230, VL UND, 10/3/20
The following user(s) said Thank You: Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16513

  • Vororo
  • Vororo's Avatar
  • Offline
  • Platinum Member
  • Platinum Member
  • Posts: 334
  • Karma: 15
  • Thank you received: 1047
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable).
Week12 (EOT): AST 30, ALT 26, VL UND
Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND
Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND
Ever grateful to Dr James.

Relapsed somewhere after all that... Bummer!

Jan 2018: VL 63 000 (still GT3).
The following user(s) said Thank You: DrJames, mgalbrai, Gaj, Matt-Kenney-google, Meg

Harvoni - decline of sales in U.S.?! 7 years 10 months ago #16516

I'm sure there were quite a few people with enough money just to self-pay when Harvoni first came out. The "Pamela Andersons" and other financially blessed suffers just bought it.
m
This email address is being protected from spambots. You need JavaScript enabled to view it.
forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
The following user(s) said Thank You: Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 9 months ago #17919

  • rohcvfighter
  • rohcvfighter's Avatar Topic Author
  • Offline
  • Platinum Member
  • Platinum Member
  • Vindecat de HCV cu med. generice. Cured with generics HCV drugs.
  • Posts: 389
  • Karma: 15
  • Thank you received: 1594
If one looks today at the stock market for Gild, will notice a nice downward trend in the last month (ref. Point 25.04.2016 till today).

Would I be too malicious if I would wish to GILD a nice and safe trip to the bottom (0$)? I mean, I am concerned about their safe journey in a similar way they care about ours.....
In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google “medicamente generice pentru hepatita C”.
HCV kills more than 500000 people every year. HCV generic drugs work. Don't become a statistic.
By sharing this Youtube video you might save someone’s life!
My TX: HEPCVIR-L[generic Harvoni]-India
SVR52 achieved
The following user(s) said Thank You: mgalbrai, Matt-Kenney-google

Harvoni - decline of sales in U.S.?! 7 years 9 months ago #17922

Gilead stock is currently trading at $83.04, down from $123.57 a year ago. A lot of things have happened since last June:
As I mentioned earlier, the people who had the money in the US, bought Harvoni as soon as it became available. That market is pretty much gone.
The insurers covered many of the sickest patients early on. There are a lot of really sick people who don't have insurance or have bad insurance coverage, however. Many are still waiting for access to treatment.
The competition has increased, forcing Gilead to negotiate lower prices for insurance companies as well as entire countries. Australia is a good example.
In addition, generics have come into play. I imagine the health tourism business in India is flourishing.
There are other factors I'm sure, but Gilead's share price seems to have stabilized around $80.00. I imagine it will stay there until someone comes up with a much shorter treatment regimen.
m
This email address is being protected from spambots. You need JavaScript enabled to view it.
forums.delphiforums.com/generichcvtx

G 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24
The following user(s) said Thank You: Matt-Kenney-google, rohcvfighter
  • Page:
  • 1
  • 2
Time to create page: 0.895 seconds

Copyright © 2015-2020 FixHepC

Back to Top